Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126656181 | 12665618 | 1 | I | 201607 | 20160808 | 20160818 | 20160818 | PER | US-TEVA-684818USA | TEVA | 54.15 | YR | F | Y | 0.00000 | 20160818 | PH | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126656181 | 12665618 | 1 | PS | COPAXONE | GLATIRAMER ACETATE | 1 | Subcutaneous | 20 MILLIGRAM DAILY; | X08901 | 20622 | 20 | MG | INJECTION | QD | |||||
126656181 | 12665618 | 2 | SS | LATANOPROST. | LATANOPROST | 1 | Unknown | U | 0 | .005 | PCT | ||||||||
126656181 | 12665618 | 3 | C | KETOCONAZOLE. | KETOCONAZOLE | 1 | 0 | 200 | MG | TABLET | |||||||||
126656181 | 12665618 | 4 | C | BRIMONIDINE | BRIMONIDINE TARTRATE | 1 | 0 | .15 | PCT | ||||||||||
126656181 | 12665618 | 5 | C | LIDODERM | LIDOCAINE | 1 | 0 | ||||||||||||
126656181 | 12665618 | 6 | C | FERROUS SULFATE. | FERROUS SULFATE | 1 | 0 | 325 | MG | TABLET | |||||||||
126656181 | 12665618 | 7 | C | CLONAZEPAM. | CLONAZEPAM | 1 | 0 | .5 | MG | TABLET | |||||||||
126656181 | 12665618 | 8 | C | CEPHALEXIN. | CEPHALEXIN | 1 | 0 | 500 | MG | CAPSULE | |||||||||
126656181 | 12665618 | 9 | C | VITAMIN D | CHOLECALCIFEROL | 1 | 0 | CAPSULE | |||||||||||
126656181 | 12665618 | 10 | C | XALATAN | LATANOPROST | 1 | 0 | .005 | PCT | ||||||||||
126656181 | 12665618 | 11 | C | DOCQLACE | DOCUSATE SODIUM | 1 | 0 | 100 | MG | CAPSULE | |||||||||
126656181 | 12665618 | 12 | C | TRAZODONE | TRAZODONE HYDROCHLORIDE | 1 | 0 | 50 | MG | TABLET | |||||||||
126656181 | 12665618 | 13 | C | PRENATAL 19 | .ALPHA.-TOCOPHEROL ACETATE, DL-.BETA.-CAROTENEASCORBIC ACIDCALCIUM CARBONATECALCIUM PANTOTHENATECHOLECALCIFEROLCYANOCOBALAMINDOCUSATE SODIUMFERROUS FUMARATEFOLIC ACIDNIACINAMIDEPYRIDOXINE HYDROCHLORIDERIBOFLAVINTHIAMINE MONONITRATEINC OXIDE | 1 | 0 | CHEWABLE TABLET | |||||||||||
126656181 | 12665618 | 14 | C | VITAMIN B12 | CYANOCOBALAMIN | 1 | 0 | 1000 | UG | ||||||||||
126656181 | 12665618 | 15 | C | OMEGA 3 | OMEGA-3 FATTY ACIDS | 1 | 0 | 1 | G | CAPSULE | |||||||||
126656181 | 12665618 | 16 | C | DECARA | 2 | 0 | CAPSULE |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
126656181 | 12665618 | 1 | Multiple sclerosis |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
126656181 | 12665618 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
126656181 | 12665618 | Optic neuritis | |
126656181 | 12665618 | Vision blurred | |
126656181 | 12665618 | Visual impairment |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
126656181 | 12665618 | 1 | 20101129 | 0 |